LessTests Overview
LessTests is focused on making COVID-19 diagnostic tests available to as many people as possible around the world. The company's suite of software solutions allows virological labs to analyze and optimize their COVID-19 polymerase-chain-reaction diagnostic throughput and protocols. Its multi-variant algorithms offer dynamically optimized diagnostic efficiency models based on environmental pandemic variables, biological variables, lab equipment, and protocols. LessTests aims to enable every person in the world to be tested for coronavirus, thereby helping families, communities, and economies return to normal.
Cumulative Funding Raised Over Time ($)
—Oct 2020
Latest News
growth-positive
היזמים הצעירים והסטארט-אפ המבטיח לבדיקות קורונה
Israeli company LessTests has developed a product that allows for up to ten individuals to be included in a single Covid-19 test. The company recently received approval from the Israeli Ministry of Health and will soon begin a pilot program with United Health Services. LessTests also received an undisclosed investment from Neopharm Group, one of Israels leading companies in the health products and services sector. The companys solution is based on a combination of pooling tests and advanced algorithmic tools.
InvestmentPartners
growth-positive
Israeli Startup LessTests Uses Single-Step Pooling Software to Multiply COVID-19 Testing Capacity
Israel-based startup LessTests has developed software that enables multiplex COVID-19 testing using a nonadaptive pooling strategy. The software has received regulatory approval from the Israeli Ministry of Health and is aimed at high-throughput labs. LessTests method splits every sample into multiple tubes, performs the test, and uses an algorithm to determine which samples are positive. The software is adaptable and can be integrated into existing lab environments. It also includes analytical tools to improve laboratory workflows. LessTests is focused on connecting with labs and understanding their challenges to make the method adaptable. The company is currently choosing local partners in different territories and aims to launch the software in major markets. LessTests is self-funded and plans to rely on revenues.
CustomersPartners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | www.lesstests.com |
Locations
Tel Aviv, Israel
Photos & Videos
No files yet
LessTests Business
Business models
B2B, B2G
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsTarget Customer
Healthcare & Life SciencesHealthcareLaboratoriesPatientsCore Technology
BiologicalsTags (9)
software-developmentdiagnosticsdigital-healthcaremedical-equipmentsaasbiotechnologylaboratoriesalgorithmstestingGeographic Markets
GlobalLessTests Financials
Undisclosed
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Seed
Funding stage
1
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
—Oct 2020
Private Equity Funding
Seed
Oct 2020
Undisclosed
Neo Pharm
LessTests Lifecycle
Cumulative Funding Raised Over Time
—Oct 2020
All Events
Seed
Oct 2020
Undisclosed
Neo Pharm
LessTests News
2 articles
growth-positive
היזמים הצעירים והסטארט-אפ המבטיח לבדיקות קורונה
Israeli company LessTests has developed a product that allows for up to ten individuals to be included in a single Covid-19 test. The company recently received approval from the Israeli Ministry of Health and will soon begin a pilot program with United Health Services. LessTests also received an undisclosed investment from Neopharm Group, one of Israels leading companies in the health products and services sector. The companys solution is based on a combination of pooling tests and advanced algorithmic tools.
InvestmentPartners
growth-positive
Israeli Startup LessTests Uses Single-Step Pooling Software to Multiply COVID-19 Testing Capacity
Israel-based startup LessTests has developed software that enables multiplex COVID-19 testing using a nonadaptive pooling strategy. The software has received regulatory approval from the Israeli Ministry of Health and is aimed at high-throughput labs. LessTests method splits every sample into multiple tubes, performs the test, and uses an algorithm to determine which samples are positive. The software is adaptable and can be integrated into existing lab environments. It also includes analytical tools to improve laboratory workflows. LessTests is focused on connecting with labs and understanding their challenges to make the method adaptable. The company is currently choosing local partners in different territories and aims to launch the software in major markets. LessTests is self-funded and plans to rely on revenues.
CustomersPartners
LessTests Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 1 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
LessTests Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 95/100 |
| Missing | video or image |
| BI Verification | Yotam Maman |
| Creator | Tsvika Vagman |
| Creator email | tsvika@lesstests.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wain@gmail.com |
| Last update | 2020-11-04T00:00:00.000Z |
| Created | 2020-06-15T00:00:00.000Z |
| Claimed | Yes |